| Title : Neurocognitive Disorders: Systematic Review of Approved (2008-2024) and Pipeline Phase III Medications - Totlani_2025_Innov.Clin.Neurosci_22_57 |
| Author(s) : Totlani J , Bashir MA , Tay L , Ngor A , Steiner AJ , Hirsch D , Contreras L , Renteria S , Danovitch I , Pechnick RN , Ishak WW , Kim S |
| Ref : Innov Clin Neurosci , 22 :57 , 2025 |
| Abstract : |
| PubMedSearch : Totlani_2025_Innov.Clin.Neurosci_22_57 |
| PubMedID: 41647067 |